在Karen Lynch上周五迅速离职后， 西维斯健康 (CVS.US)新任首席执行官David Joyner接任首席执行官一职。华尔街分析师和一些投资者质疑，在安泰医疗保险公司 ...

The change at the top, announced alongside news that CVS was withdrawing its 2024 earnings forecast and that third-quarter ...

CVS Health Chief Executive Officer Karen Lynch has stepped down and will be replaced by David Joyner, who runs the company's ...

As the new CEO at CVS, Joyner’s strategic partner will be CFO Tom Cowhey, who was promoted to the role in January after ...

CVS Health has appointed David Joyner as its new CEO, following the company’s ongoing financial challenges and missed ...

David Joyner will take over as the company heads in a new direction to stabilize its finances. CVS Health’s reshuffling has ...

CVS Health announced Friday it has appointed David Joyner as its new Chief Executive Officer, replacing Karen Lynch.

另外，西维斯健康公布的初步业绩数据显示，第三季度初步调整后 每股收益 为1.05至1.10美元，不及市场预期的1.7美元，取消了2024年的盈利指引，并警告称，“鉴于其医疗保健福利部门的医疗成本压力持续上升”，投资者不要依赖该公司此前的指引。

CVS Health (NYSE:CVS) has made a significant leadership change, replacing CEO Karen Lynch with David Joyner as the company has been struggling mightily this year. It also announced that its ...

另外，西维斯健康公布的初步业绩数据显示，第三季度初步调整后每股收益为1.05至1.10美元，不及市场预期的1.7美元，取消了2024年的盈利指引，并警告称，“鉴于其医疗保健福利部门的医疗成本压力持续上升”，投资者不要依赖该公司此前的指引。

CVS Health CEO Karen Lynch has stepped down and is being replaced by David Joyner amid struggles with rising costs.

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...